Main menu button

News

Equity research Elicera Therapeutics, Q1 2026: Stepping up following progress
12 May 2026
Equity research Elicera Therapeutics, Q1 2026: Stepping up following progress
Equity Research Elicera Therapeutics
German Digital Health: Structural Crisis, Structural Opportunity
12 May 2026
German Digital Health: Structural Crisis, Structural Opportunity
Insights
Carlsquare advised Schwabe Group on its strategic investment in NeuroNation
12 May 2026
Carlsquare advised Schwabe Group on its strategic investment in NeuroNation
Deal News
SAP Business One: M&A Trends, Valuations & the SME ERP Opportunity
11 May 2026
SAP Business One: M&A Trends, Valuations & the SME ERP Opportunity
Insights
Equity research Viva Wine Group, Q1 2026: Nordics shine in a slow market
11 May 2026
Equity research Viva Wine Group, Q1 2026: Nordics shine in a slow market
Equity Research Viva Wine Group
Equity research Immunovia Q1 2026: Initial commercialisation phase on track
11 May 2026
Equity research Immunovia Q1 2026: Initial commercialisation phase on track
Equity Research Immunovia
Equity research Candles Scandinavia, Q1 2026: A scent of synergies
08 May 2026
Equity research Candles Scandinavia, Q1 2026: A scent of synergies
Equity Research Candles Scandinavia
Processing & Packaging Machinery
08 May 2026
Processing & Packaging Machinery
Insights
Equity Research ALM Equity, Q1 2026: Additional construction starts in 2026
08 May 2026
Equity Research ALM Equity, Q1 2026: Additional construction starts in 2026
Equity Research ALM Equity
Equity research Candles, Q1 2026: On track but with margins lagging as the Örebro bet takes shape
07 May 2026
Equity research Candles, Q1 2026: On track but with margins lagging as the Örebro bet takes shape
Equity Research Candles Scandinavia
Equity research Viva Wine Group Q1 2026: Organic growth but slightly softer EBITA margin in a slow market
07 May 2026
Equity research Viva Wine Group Q1 2026: Organic growth but slightly softer EBITA margin in a slow market
Equity Research Viva Wine Group
Equity Research ALM Equity Q1 2026: Despite low revenue, there was a positive gross profit
07 May 2026
Equity Research ALM Equity Q1 2026: Despite low revenue, there was a positive gross profit
Equity Research ALM Equity
Carlsquare advised Debtist on the majority acquisition by Norvestor
06 May 2026
Carlsquare advised Debtist on the majority acquisition by Norvestor
Deal News
Carlsquare advised CamVision on its sale to Securitas
04 May 2026
Carlsquare advised CamVision on its sale to Securitas
Deal News
Carlsquare advised DBAG Fund VIII and MAIT Group on the acquisition of 4ITEGO Group
30 Apr 2026
Carlsquare advised DBAG Fund VIII and MAIT Group on the acquisition of 4ITEGO Group
Deal News
Equity Research KlaraBo, Q1 2026: A cold quarter, but continued value increases
30 Apr 2026
Equity Research KlaraBo, Q1 2026: A cold quarter, but continued value increases
Equity Research KlaraBo
Equity research Enrad, Q1 2026: A sluggish start, but the case remains intact
29 Apr 2026
Equity research Enrad, Q1 2026: A sluggish start, but the case remains intact
Equity Research Enrad
Equity Research KlaraBo, Q1 2026: Larger value increases than expected
29 Apr 2026
Equity Research KlaraBo, Q1 2026: Larger value increases than expected
Equity Research KlaraBo
Equity research Svenska Aerogel, Q1 2026: Rights issue and focus on upcoming catalysts
29 Apr 2026
Equity research Svenska Aerogel, Q1 2026: Rights issue and focus on upcoming catalysts
Equity Research Svenska Aerogel
Carlsquare advised Verso Capital on the sale of Emberion to Exosens
28 Apr 2026
Carlsquare advised Verso Capital on the sale of Emberion to Exosens
Deal News